Search

Your search keyword '"KE Xiao-Yan"' showing total 190 results

Search Constraints

Start Over You searched for: Author "KE Xiao-Yan" Remove constraint Author: "KE Xiao-Yan"
190 results on '"KE Xiao-Yan"'

Search Results

2. Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients

3. The Four types of Tregs in malignant lymphomas

5. Data-Driven Quantitative Performance Evaluation of Construction Supervisors

6. Deep Learning-Based Instance Segmentation for Indoor Fire Load Recognition

7. Intestinal Symptoms Among Children aged 2–7 Years with Autism Spectrum Disorder in 13 Cities of China

8. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial

9. Deep Learning-Based Instance Segmentation for Indoor Fire Load Recognition

16. Serum Folate Status Is Primarily Associated With Neurodevelopment in Children With Autism Spectrum Disorders Aged Three and Under—A Multi-Center Study in China

17. Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study

19. China Multi-Center Preschool Autism Project (CMPAP): Design and Methodologies to Identify Clinical Symptom Features and Biomarkers of Autism Spectrum Disorders

23. Reliability and validity of the Chinese version of Questionnaire – Children with Difficulties for Chinese children or adolescents with attention-deficit/hyperactivity disorder: a cross-sectional survey

28. P-Gemox Regimen(Pegaspargase, Gemcitabine, oxaliplatin) for Extranodal Natural Killer Cell Lymphoma: 10 Years' Real-World Clinical Experience from China

31. Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China

32. Copy number variation analysis based on AluScan sequences

34. Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens

35. Phase II study of chidamide (CS055), a new subtype-selective oral histone deacetylase inhibitor, in patients with relapsed or refractory peripheral T-cell lymphoma.

Catalog

Books, media, physical & digital resources